Condition
Sensitization, Central
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05575310Completed
Central Sensitization in Total Knee Arthroplasty Patients with Persistent Pain
NCT06440668Not ApplicableNot Yet Recruiting
Management of Chronic Non-Cancer Pain With Non-Pharmacological Therapies
NCT02976337Phase 2Completed
Effect of High-dose Naloxone Following Third Molar Extraction
NCT05494983Not ApplicableUnknownPrimary
Pain, Sleep and Gut Microbiota
Showing all 4 trials